explore -WSS

explore

author：fashion 2025-10-01 21:35:47 - browse：879

gantenerumab Alzheimer's disease Roche — Sebastien Bozon/AFP via Getty Images

LONDON — Roche on Thursday said its recently acquired experimental obesity medication helped people lose a significant amount of weight in an early trial, sending its shares up in early trading.

The drug, a once-weekly injection known as CT-388, resulted in an average placebo-adjusted weight loss of 18.8% after 24 weeks, the company said. The study was a Phase 1 trial, though it was placebo-controlled.

The reaction to such an early result — Roche shares were up roughly 4% early Thursday — is a signal both of the stakes of the obesity medication race and the keen interest investors have in the field.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Trump Jan. 6 attorney John Lauro is ex

entertainment

knowledge

WSS

Xenotransplantation trials will require adjusting expectations, experts say

We're not in Australia anymore: Kansas cops jump into action to save kangaroo

Illinois to ban advertising for guns allegedly marketed to kids and militants

More people are opting for early dinners since the pandemic, says OpenTable CEO Debby Soo

Sea level rise could wash away turtle breeding grounds around the world, researchers say

Sea level rise could wash away turtle breeding grounds around the world, researchers say

entertainment

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

focus

Alkermes shareholders re

NYC plans to house migrants on an island in the East River

Psychedelics group wrestles with new pharma identity

'The Exorcist' director William Friedkin dead at 87

ChatGPT in medicine: STAT answers readers' burning questions

DeSantis and Newsom agree to Sean Hannity debate, then disagree on the rules

As demand for Covid shots wanes, Moderna seeks its next success

Millions may soon lose Medicaid when they don't have to

Medical leaders decry Supreme Court decision on affirmative action

Moderna hits safety problems in bold bid to reinvent medicine

explore

'The Exorcist' director William Friedkin dead at 87

Living organ donors deserve priority status for transplants

Thousands of Marines and sailors deploy to Middle East to deter Iran from seizing ships

Novo: Oral version of Ozempic leads to 15% weight loss

Senate panel passes drug pricing bills, but drops one PBM reform

Biden administration plans revamp of organ transplant system

entertainment

knowledge

leisure time

hotspot